Gerresheimer's quarterly sales recovery boosts shares

FILE PHOTO: Vials produced by Gerresheimer are displayed at the annual Drug, Chemical & Associated Technologies Association (DCAT) week in New York City, U.S. March 19, 2024.

FILE PHOTO: Vials produced by Gerresheimer are displayed at the annual Drug, Chemical & Associated Technologies Association (DCAT) week in New York City, U.S. March 19, 2024. (REUTERS/Patrick Wingrove/File Photo)


1 photo
Save Story

Estimated read time: Less than a minute

Sept 30 — Gerresheimer reported a ​sequential recovery in its second-quarter revenue on Wednesday, ‌sending its shares 8% higher ⁠in early ​trading, as demand ⁠for its drug ‌delivery devices ‌boosted sales.

The German drug-packaging maker ⁠reported ⁠preliminary revenue of €578 million ($656.09 million) for the second quarter, up from €474.9 million in first quarter of ‌the financial ​year.

The company's half-year earnings before interest, taxes, depreciation and amortisation fell to €168 million from €210.4 million a year ago, but it reiterated ​that it ‌expected the ‌second ⁠half of the year to be stronger, after cutting its outlook in June.

($1 = ‌0.8810 euros)

(Reporting by ​Kira Britten ‌and Danny ⁠Callaghan ​in Gdansk, editing by Milla ​Nissi-Prussak)

Photos

Most recent Lifestyle stories

Related topics

STAY IN THE KNOW

Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Notice.
Newsletter Signup

KSL Weather Forecast

KSL Weather Forecast
Play button